Staphylococcal blepharitis.
A detailed discussion of various aspects of staphylococcal blepharitis is presented. These include epidemiology, pathogenesis and immunity, microbiologic characteristics, clinical signs, associated systemic diseases, differential diagnosis, and treatment.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001762:Blepharitis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D002908:Chronic Disease; D003231:Conjunctivitis / Q000209:etiology; D003316:Corneal Diseases / Q000209:etiology; D003320:Corneal Ulcer / Q000188:drug therapy; D003470:Culture Media; D003937:Diagnosis, Differential; D005141:Eyelid Diseases / Q000209:etiology; D006801:Humans; D007634:Keratitis / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use; D012915:Soaps / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D013210:Staphylococcus / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D003470:Culture Media; D012915:Soaps; D011239:Prednisolone